المؤلفون: Montoya B; Department of Microbiology and Immunology, Bluemle Life Science Building, Thomas Jefferson University, Philadelphia, PA 19107, USA., Melo-Silva CR; Department of Microbiology and Immunology, Bluemle Life Science Building, Thomas Jefferson University, Philadelphia, PA 19107, USA., Tang L; Department of Microbiology and Immunology, Bluemle Life Science Building, Thomas Jefferson University, Philadelphia, PA 19107, USA., Kafle S; Department of Microbiology and Immunology, Bluemle Life Science Building, Thomas Jefferson University, Philadelphia, PA 19107, USA., Lidskiy P; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA., Bajusz C; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; National Laboratory for Biotechnology, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Hungary., Vadovics M; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Abraham E; National Laboratory for Biotechnology, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Hungary; MTA SZBK Lendület Laboratory of Cell Cycle Regulation, Synthetic and Systems Biology Unit, Institute of Biochemistry, HUN-REN Biological Research Centre, Szeged, Hungary., Lipinszki Z; National Laboratory for Biotechnology, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Hungary; MTA SZBK Lendület Laboratory of Cell Cycle Regulation, Synthetic and Systems Biology Unit, Institute of Biochemistry, HUN-REN Biological Research Centre, Szeged, Hungary., Chatterjee D; Department of Neurosciences, Thomas Jefferson University Vickie and Jack Farber Institute for Neuroscience, Philadelphia, PA, USA., Scher G; Department of Microbiology and Immunology, Bluemle Life Science Building, Thomas Jefferson University, Philadelphia, PA 19107, USA., Benitez J; Department of Microbiology and Immunology, Bluemle Life Science Building, Thomas Jefferson University, Philadelphia, PA 19107, USA., Sung MMH; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada., Tam YK; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada., Catanzaro NJ; Department of Epidemiology, Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Schäfer A; Department of Epidemiology, Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Andino R; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA., Baric RS; Department of Epidemiology, Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Martinez DR; Department of Immunobiology, Center for Infection and Immunity, Yale School of Medicine, New Haven, CT 06520, USA., Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: pnorbert@pennmedicine.upenn.edu., Sigal LJ; Department of Microbiology and Immunology, Bluemle Life Science Building, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address: luis.sigal@jefferson.edu.

المصدر: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Jun 05; Vol. 32 (6), pp. 1790-1804. Date of Electronic Publication: 2024 Apr 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/immunology , SARS-CoV-2*/immunology , COVID-19*/immunology , COVID-19*/prevention & control , Spike Glycoprotein, Coronavirus*/immunology , Spike Glycoprotein, Coronavirus*/genetics , COVID-19 Vaccines*/immunology , Antibodies, Viral*/immunology, Animals ; Mice ; Female ; Male ; Mice, Inbred C57BL ; Humans ; Disease Models, Animal

المؤلفون: Schäfer A; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: aschaefe@email.unc.edu., Marzi A; Laboratory of Virology, Division of Intramural Research, NIAID, NIH, Hamilton, MT 59840, USA. Electronic address: marzia@niaid.nih.gov., Furuyama W; Laboratory of Virology, Division of Intramural Research, NIAID, NIH, Hamilton, MT 59840, USA., Catanzaro NJ; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., Nguyen C; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., Haddock E; Laboratory of Virology, Division of Intramural Research, NIAID, NIH, Hamilton, MT 59840, USA., Feldmann F; Rocky Mountain Veterinary Branch, Division of Intramural Research, NIAID, NIH, Hamilton, MT 59840, USA., Meade-White K; Laboratory of Virology, Division of Intramural Research, NIAID, NIH, Hamilton, MT 59840, USA., Thomas T; Rocky Mountain Veterinary Branch, Division of Intramural Research, NIAID, NIH, Hamilton, MT 59840, USA., Hubbard ML; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., Gully KL; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., Leist SR; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., Hock P; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA., Bell TA; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA., De la Cruz GE; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA., Midkiff BR; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA., Martinez DR; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., Shaw GD; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA., Miller DR; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA., Vernon MJ; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA., Graham RL; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., Cowley DO; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA; Animal Models Core Facility, University of North Carolina, Chapel Hill, NC 27599, USA., Montgomery SA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA., Schughart K; Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN 38163, USA; Institute of Virology, University of Muenster, 48149 Muenster, Germany., de Villena FPM; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA., Wilkerson GK; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA., Ferris MT; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA., Feldmann H; Laboratory of Virology, Division of Intramural Research, NIAID, NIH, Hamilton, MT 59840, USA., Baric RS; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: rbaric@email.unc.edu.

المصدر: Cell reports [Cell Rep] 2024 May 28; Vol. 43 (5), pp. 114127. Date of Electronic Publication: 2024 Apr 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Hemorrhagic Fever, Ebola*/virology , Hemorrhagic Fever, Ebola*/genetics , Hemorrhagic Fever, Ebola*/pathology , Quantitative Trait Loci*/genetics , Ebolavirus*/pathogenicity , Ebolavirus*/genetics , Genetic Predisposition to Disease*, Animals ; Mice ; Mice, Knockout ; Chromosome Mapping ; Liver/pathology ; Liver/metabolism ; Humans ; Mice, Inbred C57BL ; Female ; Male

المؤلفون: Martinez DR; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA.; Yale Center for Infection and Immunity, Yale School of Medicine, New Haven, CT 06510, USA., Moreira FR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Diefenbacher MV; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Zweigart MR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Gully KL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., De la Cruz G; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA., Brown AJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Adams LE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Yount B; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Baric TJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Mallory ML; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Conrad H; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., May SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Dong S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Scobey DT; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Nguyen C; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Montgomery SA; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA., Perry JK; Gilead Sciences, Inc., Foster City, CA 94404, USA., Babusis D; Gilead Sciences, Inc., Foster City, CA 94404, USA., Barrett KT; Gilead Sciences, Inc., Foster City, CA 94404, USA., Nguyen AH; Gilead Sciences, Inc., Foster City, CA 94404, USA., Nguyen AQ; Gilead Sciences, Inc., Foster City, CA 94404, USA., Kalla R; Gilead Sciences, Inc., Foster City, CA 94404, USA., Bannister R; Gilead Sciences, Inc., Foster City, CA 94404, USA., Feng JY; Gilead Sciences, Inc., Foster City, CA 94404, USA., Cihlar T; Gilead Sciences, Inc., Foster City, CA 94404, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Mackman RL; Gilead Sciences, Inc., Foster City, CA 94404, USA., Bilello JP; Gilead Sciences, Inc., Foster City, CA 94404, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

المصدر: Science translational medicine [Sci Transl Med] 2024 May 22; Vol. 16 (748), pp. eadj4504. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2*/drug effects , Prodrugs*/pharmacology , Prodrugs*/therapeutic use , Antiviral Agents*/pharmacology , Antiviral Agents*/therapeutic use, Animals ; Humans ; Mice ; Administration, Oral ; Chlorocebus aethiops ; Vero Cells ; COVID-19 Drug Treatment ; COVID-19/virology ; Virus Replication/drug effects ; Nucleosides/pharmacology ; Nucleosides/therapeutic use ; Nucleosides/chemistry ; Coronavirus Infections/drug therapy ; Coronavirus Infections/virology ; Female ; Disease Models, Animal

SCR Organism: SARS-CoV-2 variants

المؤلفون: Philip DT; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Goins NM; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Catanzaro NJ; Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Misumi I; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Whitmire JK; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Atkins HM; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lazear HM; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

المصدر: MBio [mBio] 2024 Apr 10; Vol. 15 (4), pp. e0262323. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2150-7511 (Electronic) NLM ISO Abbreviation: mBio Subsets: MEDLINE

مواضيع طبية MeSH: Herpes Simplex* , Herpesvirus 1, Human*, Humans ; Mice ; Animals ; Interferon Lambda ; Neutrophils ; Cytokines ; Interferon-alpha ; Mice, Knockout ; Antiviral Agents/pharmacology

المؤلفون: Chao CW; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Graduate Program in Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, USA., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Miranda MC; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA., Hubbard ML; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA., Addetia A; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Stewart C; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Brown JT; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Dosey A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Valdez A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Ravichandran R; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Hendricks GG; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Ahlrichs M; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Dobbins C; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Hand A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Treichel C; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Willoughby I; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., McGuire AT; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Leaf EM; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, Seattle, WA 98195, USA., King NP; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 14. Date of Electronic Publication: 2024 Mar 14.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Diefenbacher MV; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Baric TJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Martinez DR; Department of Immunobiology, Yale School of Medicine, New Haven, CT, United States., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address: nick_catanzaro@med.unc.edu., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

المصدر: Virus research [Virus Res] 2024 Jan 02; Vol. 339, pp. 199286. Date of Electronic Publication: 2023 Dec 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8410979 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7492 (Electronic) Linking ISSN: 01681702 NLM ISO Abbreviation: Virus Res Subsets: MEDLINE

مواضيع طبية MeSH: Coronavirus OC43, Human*/genetics , Coronavirus*/genetics , Coronavirus Infections*, Humans ; Viral Proteins ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use

المؤلفون: Kapingidza AB; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Marston DJ; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Harris C; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Wrapp D; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Winters K; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Mielke D; Department of Surgery, Duke University, Durham, NC, USA.; Center for Human Systems Immunology, Duke University, Durham, NC, USA., Xiaozhi L; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Yin Q; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Foulger A; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Parks R; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Barr M; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Newman A; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Eaton A; Department of Surgery, Duke University, Durham, NC, USA., Flores JM; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Harner A; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Catanzaro NJ Jr; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mallory ML; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mattocks MD; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Beverly C; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Rhodes B; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Mansouri K; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Van Itallie E; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Vure P; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Dunn B; Department of Surgery, Duke University, Durham, NC, USA., Keyes T; Department of Surgery, Duke University, Durham, NC, USA., Stanfield-Oakley S; Department of Surgery, Duke University, Durham, NC, USA., Woods CW; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA.; Center for Infectious Diseases and Diagnostic Innovation, Duke University Medical Center, Durham, NC, USA., Petzold EA; Center for Infectious Diseases and Diagnostic Innovation, Duke University Medical Center, Durham, NC, USA., Walter EB; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Pediatrics, Duke University, Durham, NC, USA., Wiehe K; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Edwards RJ; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Montefiori DC; Department of Surgery, Duke University, Durham, NC, USA., Ferrari G; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Surgery, Duke University, Durham, NC, USA.; Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA., Baric R; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Cain DW; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA., Saunders KO; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Surgery, Duke University, Durham, NC, USA.; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.; Department of Immunology, Duke University, Durham, NC, USA., Haynes BF; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Medicine, Duke University, Durham, NC, USA.; Department of Immunology, Duke University, Durham, NC, USA., Azoitei ML; Duke Human Vaccine Institute, Duke University, Durham, NC, USA. mihai.azoitei@duke.edu.; Department of Medicine, Duke University, Durham, NC, USA. mihai.azoitei@duke.edu.

المصدر: Nature communications [Nat Commun] 2023 Nov 30; Vol. 14 (1), pp. 7897. Date of Electronic Publication: 2023 Nov 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Viral* , SARS-CoV-2*, Humans ; Animals ; Mice ; Epitopes ; Immunodominant Epitopes ; Peptides ; Spike Glycoprotein, Coronavirus ; Antibodies, Neutralizing

المؤلفون: Martinez DR; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA; Yale Center for Infection and Immunity, Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: david.martinez@yale.edu., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Gavitt TD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Mallory ML; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Lee E; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Chen H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Gully K; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Scobey T; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Korategere P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Brown A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Smith L; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Barr M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Newman A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Bowman C; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Powers JM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Soderblom EJ; Proteomics and Metabolomics Core Facility, Duke University School of Medicine, Durham, NC 27710, USA., Mansouri K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: rbaric@email.unc.edu., Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu., Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kevin.saunders@duke.edu.

المصدر: Cell reports [Cell Rep] 2023 Oct 31; Vol. 42 (10), pp. 113248. Date of Electronic Publication: 2023 Oct 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Middle East Respiratory Syndrome Coronavirus* , Severe acute respiratory syndrome-related coronavirus*, Animals ; Humans ; Mice ; COVID-19 Vaccines ; Antibodies, Viral ; Antibodies, Neutralizing ; SARS-CoV-2

المؤلفون: Hou YJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Moderna Inc., Cambridge, MA, USA., Chiba S; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA., Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Meganck RM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Martinez DR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sontake V; Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA., West A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Edwards CE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Yount B; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lee RE; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gallant SC; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Zost SJ; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Powers J; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Adams L; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kong EF; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mattocks M; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tata A; Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA., Randell SH; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tata PR; Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA., Halfmann P; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA.; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.

المصدر: Nature microbiology [Nat Microbiol] 2023 Oct; Vol. 8 (10), pp. 1820-1833. Date of Electronic Publication: 2023 Sep 25.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101674869 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2058-5276 (Electronic) Linking ISSN: 20585276 NLM ISO Abbreviation: Nat Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , Severe acute respiratory syndrome-related coronavirus*, Cricetinae ; Humans ; Animals ; Mice ; Host Specificity ; Pangolins ; SARS-CoV-2/genetics ; Antibodies, Viral ; COVID-19 Vaccines ; Mice, Inbred BALB C

المؤلفون: Philip DT; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill., Goins NM; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill., Catanzaro NJ; Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill., Misumi I; Department of Genetics, University of North Carolina at Chapel Hill., Whitmire JK; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill.; Department of Genetics, University of North Carolina at Chapel Hill., Atkins HM; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill., Lazear HM; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 14. Date of Electronic Publication: 2023 Sep 14.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE